• Explore /
  • Poster
  • / Indirect comparison of TAK-788 vs real-world data outcomes in refractory non-small cell lung cancer (NSCLC) with <em>EGFR</em> exon 20 insertions.

Indirect comparison of TAK-788 vs real-world data outcomes in refractory non-small cell lung cancer (NSCLC) with EGFR exon 20 insertions.

Abstract Video & Slides Poster

Authors

Leora Horn

Leora Horn

Vanderbilt-Ingram Cancer Center, Nashville, TN

Leora Horn , Huamao Mark Lin , Sukhmani Kaur Padda , Charu Aggarwal , Caroline Elizabeth McCoach , Yanyan Zhu , Yu Yin , Jianchang Lin , Shuanglian Li , Zhongling Feng , Joel W. Neal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT02716116

Citation

J Clin Oncol 38: 2020 (suppl; abstr 9580)

DOI

10.1200/JCO.2020.38.15_suppl.9580

Abstract #

9580

Poster Bd #

346

Abstract Disclosures

Similar Posters

First Author: Justin Nathaniel Malinou

First Author: Daniel Adam Breadner

First Author: Federico Cappuzzo

First Author: Helena Alexandra Yu